KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Working Capital Changes (2016 - 2025)

Eli Lilly's Other Working Capital Changes history spans 17 years, with the latest figure at -$3.8 billion for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 219.94% year-over-year to -$3.8 billion; the TTM value through Dec 2025 reached $620.0 million, down 81.39%, while the annual FY2025 figure was $620.0 million, 81.39% down from the prior year.
  • Other Working Capital Changes reached -$3.8 billion in Q4 2025 per LLY's latest filing, down from $4.0 billion in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $4.0 billion in Q3 2025 to a low of -$3.8 billion in Q4 2025.
  • Average Other Working Capital Changes over 5 years is $160.8 million, with a median of $82.7 million recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: plummeted 998.22% in 2021, then skyrocketed 4022.04% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$2.0 billion in 2021, then surged by 107.39% to $149.2 million in 2022, then skyrocketed by 192.36% to $436.2 million in 2023, then soared by 626.11% to $3.2 billion in 2024, then crashed by 219.94% to -$3.8 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Other Working Capital Changes are -$3.8 billion (Q4 2025), $4.0 billion (Q3 2025), and -$3.0 billion (Q2 2025).